Perspective Therapeutics, Inc. financial data

Symbol
CATX on NYSE
Industry
Surgical & Medical Instruments & Apparatus
Location
2401 Elliott Avenue, Suite 320, Seattle, WA
State of incorporation
DE
Fiscal year end
December 31
Former names
IsoRay, Inc. (to 2/16/2023), Isoray, Inc. (to 2/16/2023), CENTURY PARK PICTURES CORP (to 8/3/2005)
Latest financial report
10-K/A - Q4 2024 - Mar 28, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.38K % +392%
Quick Ratio 18.2 % -64.6%
Debt-to-equity 17.4 % +25.1%
Return On Equity -26.7 % +42.6%
Return On Assets -22.7 % +44.3%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 74.1M shares -87.4%
Common Stock, Shares, Outstanding 70.7M shares +151%
Entity Public Float 186M USD +328%
Common Stock, Value, Issued 70K USD +150%
Weighted Average Number of Shares Outstanding, Basic 64.4M shares +141%
Weighted Average Number of Shares Outstanding, Diluted 64.4M shares +141%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 2.19M USD +27.3%
Research and Development Expense 41.6M USD +95.4%
Selling and Marketing Expense 855K USD +6.88%
General and Administrative Expense 26.6M USD +26.3%
Operating Income (Loss) -90.9M USD -122%
Nonoperating Income (Expense) 10.5M USD +1153%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -80.4M USD -101%
Income Tax Expense (Benefit) -2.65M USD
Net Income (Loss) Attributable to Parent -79.3M USD -70.5%
Earnings Per Share, Basic -1.23 USD/shares +29.3%
Earnings Per Share, Diluted -1.23 USD/shares +29.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 61.6M USD +567%
Cash, Cash Equivalents, and Short-term Investments 227M USD
Accounts Receivable, after Allowance for Credit Loss, Current 116K USD -90%
Inventory, Net 1.01M USD -34.8%
Other Assets, Current 81K USD +80%
Assets, Current 231M USD +1273%
Property, Plant and Equipment, Net 57.3M USD +928%
Operating Lease, Right-of-Use Asset 2.22M USD +197%
Intangible Assets, Net (Excluding Goodwill) 279K USD -21.2%
Goodwill 0 USD -100%
Other Assets, Noncurrent 405K USD -16.8%
Assets 341M USD +248%
Employee-related Liabilities, Current 5.48M USD +52.7%
Liabilities, Current 18.2M USD +16.4%
Deferred Income Tax Liabilities, Net 2.5M USD -45.7%
Operating Lease, Liability, Noncurrent 1.43M USD +83.1%
Other Liabilities, Noncurrent 55K USD
Liabilities 50.4M USD +122%
Accumulated Other Comprehensive Income (Loss), Net of Tax -51K USD
Retained Earnings (Accumulated Deficit) -232M USD -52%
Stockholders' Equity Attributable to Parent 291M USD +287%
Liabilities and Equity 341M USD +248%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 13.8M USD
Net Cash Provided by (Used in) Financing Activities 166M USD
Net Cash Provided by (Used in) Investing Activities -47.3M USD -287%
Common Stock, Shares Authorized 750M shares 0%
Common Stock, Shares, Issued 70.7M shares +151%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 133M USD +760%
Deferred Tax Assets, Valuation Allowance 41.8M USD +39.6%
Deferred Tax Assets, Gross 50.8M USD +30.9%
Operating Lease, Liability 2.39M USD +189%
Depreciation 346K USD +92.2%
Payments to Acquire Property, Plant, and Equipment 9.07M USD +4413%
Lessee, Operating Lease, Liability, to be Paid 2.7M USD +154%
Property, Plant and Equipment, Gross 60.3M USD +865%
Operating Lease, Liability, Current 957K USD +1980%
Lessee, Operating Lease, Liability, to be Paid, Year Two 647K USD +166%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.11M USD +902%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Deferred Income Tax Expense (Benefit) -2.1M USD +20.9%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 310K USD +32.5%
Lessee, Operating Lease, Liability, to be Paid, Year Three 493K USD +106%
Deferred Tax Assets, Operating Loss Carryforwards 35.3M USD +31.9%
Preferred Stock, Shares Authorized 7M shares 0%
Unrecognized Tax Benefits 526K USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 443K USD +92.6%
Deferred Tax Assets, Net of Valuation Allowance 9M USD +1.49%
Share-based Payment Arrangement, Expense 5.22M USD +66.1%
Interest Expense 84 USD
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%